Spectrum of narcolepsy

Narcolepsy and Hypersomnia

Volumn , Issue , 2006, Pages 97-108

  Bassetti, Claudio L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056686818     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Westphal C. Eigentümliche mit Einschlafen verbundene Anfälle. Archiv fü r Psychiatrie und Nervenkrankheiten 1877; 7:631-635.
2. Gélineau JBE. De la narcolepsie. Gazette des Hôpitaux 1880; 53, 54:626-628, 35-37.
3. Löwenfeld L. Ueber Narkolepsie. Münchner Medizinische Wochenschrift 1902; 49:1041-1045.
4. Henneberg R. Ueber genuine Narkolepsie. Neurol Zbl 1916; 30:282-290.
5. Adie WJ. Idiopathic narcolepsy: a disease sui generis: with remarks on the mechanism of sleep. Brain 1926; 49:257-306.
6. Redlich E. Ueber Narkolepsie. Zeitschrift fü r die gesamte Neurologie und Psychiatrie 1924; 95:256-270.
7. Blocq P. Semeiology of sleep. Brain 1891; 14:112-126.
8. Wilson SA. The narcolepsies. Brain 1928; 51:63-109.
9. Redlich E. Epilegomena zur Narkolepsiefrage. Zeitschrift für Gesundheit Psychiatrie und Neurologie 1931; 136:129-173.
10. Daniels LE. Narcolepsy. Medicine 1934; 13:1-122.
11. Wilder J, ed. Narkolepsie. Berlin: Springer, 1935.
12. Yoss RE, Daly DD. Criteria for the diagnosis of the narcoleptic syndrome. Mayo Clinic Proceedings 1957; 32:320-328.
13. Parkes JD, Baraitser M, Marsden CD, Asselman P. Natural history, symptoms and treatment of the narcoleptic syndrome. Acta Neurologica Scandinavica 1975; 52(5):337-353.
14. Aldrich M. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996; 46:393-401.
15. Sturzenegger C, Bassetti C. The clinical spectrum of narcolepsy with cataplexy: A reappraisal. J Sleep Res 2004; 13:395-406.
16. Bassetti C, Aldrich M. Idiopathic Hypersomnia. A study of 42 patients. Brain 1997; 120:1423-1435.
17. Bassetti C, Gugger M, Bischof M, et al. The narcoleptic borderland: A multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med 2003; 4:7-12.
18. Bassetti CL. Idiopathic hypersomnia. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: Elsevier Saunders; 2005.
19. Vogel G. Studies in psychophysiology of dreams III. The dreams of narcolepsy. Archives of general psychiatry 1960; 3:421-428.
20. Rechtschaffen A, Wolpert W, Dement W, Mitchell S, Fischer C. Nocturnal sleep of narcoleptics. Electroencephalography and Clinical Neurophysiology 1963; 15:599-609.
21. Passouant P, Schwab RS, Cadilhac J, Baldy-Moulinier M. Narcolepsie-Cataplexie. Etude du sommeil de nuit et du sommeil de jour. Revue Neurologique 1964; 111:415-426.
22. Dement W, Rechtschaffen A, Gulevich G. The nature of the narcoleptic sleep attack. Neurology 1966; 16:18-33.
23. Berti Ceroni G, Coccagna G, Gambi D, Lugaresi E. Considerazioni clinico-poligrafiche sulla narcolessia essenziale “a sonno lento.” Sistema Nervoso 1967; 2:81-89.
24. Hishikawa Y, Nanno H, Tachibana M, Furuya E, Koida H, Kaneko Z. The nature of sleep attack and other symptoms of narcolepsy. Electroencephalography and Clinical Neurophysiology 1968; 24.
25. Roth B, Bruhovà S, Lehovskù M. REM sleep and NREM sleep in narcolepsy and hypersomnia. Electroencephalography and Clinical Neurophysiology 1969; 26:176-182.
26. Honda Y, Asaka A, Tanaka Y, Juji T. Discrimination of narcolepsy by using genetic markers and HLA. Sleep Research 1983; 12:254.
27. Nishino N, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355:39-40.
28. Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001; 50:381-388.
29. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59:1553-1562.
30. Bishop C, Rosenthal L, Helmus T, Roehrs T, Roth T. The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness. Sleep 1996; 19(9):727-730.
31. Chervin RD, Aldrich M. Specificity of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Neurology 1995; 45 (Suppl 4):A432-A433 (abstract).
32. Mignot E, Young T, Lin L, Finn L, Palta M. Reduction of REM sleep latency associated with HLA-DQB10602 in normal adults. Lancet 1998; 351:727.
33. Mignot E, Lin L, Finn L, et al. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 2006; (in press).
34. Roth B. Narkolepsie und Hypersomnie. In: Roth B, ed. Narkolepsie und Hypersomnie. Berlin: VEB Verlag; 1962.
35. Roth B. Narcolepsy and hypersomnia. Basel: Karger Libri; 1980.
36. Moscowitch A, Partinen M, Guilleminault C. The positive diagnosis of narcolepsy and narcolepsy’s borderland. Neurology 1993; 43:55-60.
37. Yoss RE, Daly DD. Narcolepsy. Medical Clinics of North America 1960; 44:955-968.
38. Billiard M, Besset A, Cadilhac J. The clinical and polygraphic development of narcolepsy. In: Guilleminault C, Lugaresi E, eds. Sleep/Wake disorders: Natural history, epidemiology, and longterm evolution. New York: Raven Press; 1983:171-185.
39. Daly DD, Yoss RE. A family with narcolepsy. Mayo Clinic Proceedings 1959; 34:313-319.
40. Nevsimalova S, Mignot E, Sonka K, Arrigoni JL. Familial aspects of narcolepsy-cataplexy in the Czech republic. Sleep 1997; 20:1021-1026.
41. Baumann CR, Dauvilliers Y, Maly FE, Mignot E, Bassetti CL. Normal CSF-1 (orexin-A) levels in dementia with diffuse Lewy bodies. Eur Neurol 2004; (in press).
42. Baumann C, Khatami R, Werth E, Bassetti CL. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J Neurol Neurosurg Psychiatry 2006; 77:402-404.
43. American Academy of Sleep M. The International Classification of Sleep Disorders. Second Edition ed; 2005.
44. Guilleminault C, Mignot E, Partinen M. Controversies in the diagnosis of narcolepsy. Sleep 1994; 17:S1-S6.
45. Mignot E, Hajduk R, Black J, Grumet FC, Guilleminault C. HLA DQB10602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997; 20(11):1012-1020.
46. Dauvilliers Y, Baumann CR, Maly FE, Billiard M, Bassetti C. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, other hypersomnias and neurological conditions. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74(1667-1673).
47. Baumann C, Bassetti CL. Hypocretin and narcolepsy. Lancet Neurology 2005; 10:673-682.
48. Krahn LE, Pankratz VS, Olivier L, Boeve BF, Silber M. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: Relationship to cataplexy and HLA DQB10602 status. Sleep 2002; 25(7):733-736.
49. Challamel MJ, Mazzola ME, Nevsimalova S, Cannard C, Louis J, Revol M. Narcolepsy in children. Sleep 1994; 17:17-20.
50. Gelardi JAM, Brown JW. Hereditary cataplexy. Journal of Neurology, Neurosurgery, and Psychiatry 1967; 30:455-457.
51. Hartse KM, Zorick F, Sicklesteel J, Roth T. Isolated cataplexy: A familial study. Henry Ford Hosp Med J 1988; 36:24-27.
52. Roth B, Bruhova S, Berkova L. Familial sleep paralysis. Schweizer Archiv fü r Neurologie und Psychiatrie 1968; 102:321-330.
53. Nevsimalova-Bruhova S, Roth B. Heredofamilial aspects of narcolepsy and hypersomnia. Schweizer Archiv für Neurologie und Psychiatrie 1972; 110:45-54.
54. Guilleminault C, Mignot E, Grumet FC. Familial patterns of narcolepsy. Lancet 1989; 335:1376-1379.
55. Billiard M, Pasquié-Magnetto V, Heckmann M, et al. Family studies in narcolepsy. Sleep 1994; 17:S54-S59.
56. Mayer G, Lattermann A, Mueller-Echardt G, Sbanborg E, Meier-Ewert K. Segregation of HLA genes in multicase narcolepsy families. J Sleep Res 1998; 7:127-133.
57. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998; 50 (Suppl 1):S16-S22.
58. Ekbom K. Familial multiple sclerosis associated with narcolepsy. Archives of Neurology 1966; 15:337-344.
59. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980; 30(1):105-108.
60. Melberg A, Hetta J, Dahl N, Nennesmo I, et al. Autosomal dominant cerebellar ataxia deafness and narcolepsy. Journal of Neurological Sciences 1995; 134:119-129.
61. Dahlitz M, Parkes JD. Sleep paralysis. Lancet 1993; 341:406-407.
62. Partinen M, Hublin C, Kaprio J, Koskenvuo M, Guilleminault C. Twin studies in narcolepsy. Sleep 1994; 17:S13-S16.
63. Kaprio J, Hublin C, Partinen M, Heikkilä K, Koskenvuo M. Narcolepsy-like symptoms among adult twins. Journal of Sleep Research 1996; 5(1):55-60.
64. Honda M, Honda Y, Uchida S, Miyazaki S, Tokunaga K. Monozygotic twins incompletely concordant for narcolepsy. Biol Psychiatry 2001; 49:943-947.
65. Khatami R, Maret S, Werth E, et al. A monozygotic twin pair concordant for narcolepsycataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet 2004; 363:1199-1200.
66. Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999; 22:77-87.
67. Onofrij M, Curatola L, Ferracci F, Fulgente T. Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject. Journal of Neurology, Neurosurgery, and Psychiatry 1992; 55:852-853.
68. Bonduelle M, Degos C. Symptomatic narcolepsies: a critical study. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy Proceedings of the First International Symposium on Narcolepsy. Montpellier, France: Spectrum Publications, Inc.; 1976:313-332.
69. Lankford DA, Wellmann JJ, O’Hara C. Posttraumatic narcolepsy in mild to moderate closed head injury. Sleep 1994; 17:25-28.
70. Schwartz WJ, Stakes JW, Hobson JA. Transient cataplexy after removal of a craniopharyngioma. Neurology 1984; 34:1372-1375.
71. Aldrich MS, Naylor MW. Narcolepsy associated with lesions of the diencephalon. Neurology 1989; 39:1505-1508.
72. Gledhill RF, Bartel PR, Yoshida Y, Nishino H, Scammell T. Narcolepsy caused by acute disseminated encephalomyelitis. Arch Neurol 2004; 61(5):758-760.
73. Stahl SM, Layzer RB, Aminoff MJ, Townsend JJ, Feldon S. Continuous cataplexy in a patient with a midbrain tumor: The limp man syndrome. Neurology 1980; 30:1115-1118.
74. D’Cruz OF, Vaughn BV, Gold SH, Greenwood RS. Symptomatic cataplexy in pontomedullary lesions. Neurology 1994; 44:2189-2191.
75. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy, and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005; 9:269-310.
76. Scammell TE, Nishino S, Mignot E, Saper CB. Narcolepsy and low CSF orexin (hypocretin) concentration after stroke. Neurology 2001; 56:1751-1753.
77. Dempsey OJ, McGeoch P, de Silva RN, Douglas NJ. Acquired narcolepsy in an acromegalic patient who underwent pituitary irradiation. Neurology 2003; 61:537-540.
78. Lagrange AH, Blaivas M, Gomez-Hassan D, Malow BA. Ramussen’s syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult. Epilepsy and behavior 2003; 4:788-792.
79. Willey MM. Sleep as an escape mechanism. Psychoanalytic review 1924; 11:181-183.
80. Missriegler A. On the psychogenesis of narcolepsy. Journal of Nervous and Mental Diseases 1941; 93:141-162.
81. Pai MN. Hypersomnia syndromes. British Medical Journal 1950; 1:522-524.
82. Orellana C, Villemin E, Tafti M, Carlander B, Besset A, Billiard M. Life events in the year preceding the onset of narcolepsy. Sleep 1994; 17:S50-S53.
83. Roth B, Nevsimalova S. Depression in narcolepsy and hypersomnia. Schweizer Archiv für Neurologie und Psychiatrie 1975; 116:291-300.
84. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 1998; 50(Suppl 1):S31-S36.
85. Douglass AB, Hays P, Pazderka F, Russell JM. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. Journal of Nervous and Mental Diseases 1991; 179:12-17.
86. Kishi Y, Konishi S, Koizumi S, et al. Schizophrenia and narcolepsy: A review with a case report. Psychiatry and Clinical Neurosciences 2004; 58:117-124.
87. Rosenthal C. Ueber das Auftreten von halluzinatorisch-kataplektischen Angstsyndrom, Wachanfällen und ähnlichen Störungen bei Schizophrenen. Monatschrift fü r Psychiatrie und Neurologie 1939; 102:11-38.
88. Bassetti C, Aldrich M. Narcolepsy. Neurologic Clinics of North America 1996; 14:545-571.
89. Krahn LE, Hansen MR, Shepard JW. Pseudocataplexy, Psychosomatics 2001; 42:356-358.
90. Ohayon M, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena. British Journal of Psychiatry 1996; 169:459-467.
91. Ohayon MM, Zulley J, Guilleminault C, Smirne S. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology 1999; 52(6):1194-1200.
92. Ohayon M. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Research 2000; 97.
93. Nissen C, Feige B, Nofzinger EA, et al. Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine. J Sleep Res 2005; 14(2):207-208.
94. US Xyrem Multicenter Study G. A randomized, double-blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002; 25(1):42-49.
95. Maret S, Tafti M. Genetics of narcolepsy and other major sleep disorders. Swiss Med Wkly 2005; 135:662-665.
96. Bassetti C. Selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies. Neurology 2005; 65:1152-1153.